A pilot study of virtual reality for inpatients with opioid use disorder.

Autor: Greenwald HJ; 3D Therapy, LLC, Beverly, Massachusetts, USA.; Department of Psychology, Bridgewater State University, Bridgewater, Massachusetts, USA., Berger A; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Wilson RLH; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Greenwald DJ; 3D Therapy, LLC, Beverly, Massachusetts, USA., Lannon E; 3D Therapy, LLC, Beverly, Massachusetts, USA., Johnson-Smith P; 3D Therapy, LLC, Beverly, Massachusetts, USA., Bergman BG; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Wilens TE; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Jazyk: angličtina
Zdroj: The American journal on addictions [Am J Addict] 2024 Jul; Vol. 33 (4), pp. 423-429. Date of Electronic Publication: 2024 Mar 02.
DOI: 10.1111/ajad.13526
Abstrakt: Background and Objectives: While inpatient withdrawal management/acute stabilization can improve outcomes for individuals with opioid use disorder (OUD), patients often leave treatment early due to mood, tension, and cravings associated with opioid withdrawal. The aim of this study was to evaluate the feasibility and preliminary effectiveness of a novel virtual reality (VR) based intervention; 3D Therapy Thrive (3DTT).
Methods: Subjects with OUD (N = 32) were recruited from a community acute stabilization program and received up to two sessions of 3DTT. They completed questionnaires related to their overall satisfaction with the experience and side effects; as well as those related to mood, tension, and cravings.
Results: There were no reported side effects and the majority of subjects (94%) reported high satisfaction with the experience. Out of 62 patients approached, 33 patients agreed to participate (53%) 33 patients completed one, and 17 of these patients (52%) completed both sessions of 3DTT, with 19 participants (58%) completing their treatment protocols. Compared to baseline, 3DTT participants reported significant reductions in depression, tension, and cravings (p's < 0.001).
Discussion and Conclusions: This pilot study supports the feasibility and preliminary effectiveness of 3DTT for improving outcomes for inpatients with OUD. Future randomized controlled trials are necessary to evaluate the efficacy of 3DTT for improving retention, reducing cravings, and improving mood and tension.
Scientific Significance: This is the first study to evaluate the feasibility of a psychologically informed VR intervention in inpatients with OUD.
(© 2024 The American Academy of Addiction Psychiatry (AAAP).)
Databáze: MEDLINE
Externí odkaz: